India Liberalizes Foreign Investments But Will Money Flow?
This article was originally published in PharmAsia News
Executive Summary
Following the easing of India’s foreign direct investment norms in the pharmaceutical sector, reforms are expected to buoy foreign capital inflows and investor sentiment, especially private equity, though some opponents claim it may potentially have a dire impact on India's future medicines security.